NCT01193127View on ClinicalTrials.gov

Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)

PHASE2CompletedINTERVENTIONAL

Enrollment

223

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions

Cataract

Interventions

DRUG

OMS302 Solution

DRUG

OMS302 Mydriatic Solution

DRUG

OMS302 Anti-inflammatory Solution

DRUG

Balanced Salt Solution (BSS) Solution

Trial Locations (24)

11570

Rockville Centre

19004

Bala-Cynwyd

32405

Panama City

33321

Tamarac

33770

Largo

33903

North Fort Myers

37072

Goodlettsville

60031

Gurnee

63131

St Louis

64111

Kansas City

68131

Omaha

70056

Gretna

72205

Little Rock

75965

Nacogdoches

77024

Houston

78229

San Antonio

78731

Austin

80134

Parker

84132

Salt Lake City

85224

Chandler

85308

Glendale

87113

Albuquerque

89135

Las Vegas

90013

Los Angeles

Sponsors

Lead Sponsor

Omeros Corporation

All Listed Sponsors

lead

Omeros Corporation

INDUSTRY